Pre-Clinical Models of Heart Failure with Preserved Ejection Fraction: Advancing Knowledge for Device Based Therapies
Year: 2025
Type: review
Abstract: Heart failure with preserved ejection fraction (HFpEF) is a growing health problem worldwide, accounting for half of all heart failure cases. HFpEF patients present with diverse underlying causes and symptoms, making diagnosis and treatment challenging. Current pharmacological therapies are inadequate, while approved device-based therapies have shown limited success due to patient heterogeneity. This underscores the need for improved pre-clinical models, critical for guiding the design and development of effective therapeutic devices. This paper presents an overview of current pre-clinical HFpEF models, including in-silico, in-vitro, ex-vivo, and in-vivo approaches, aimed at advancing the understanding of HFpEF physiology and the development of device-based therapies. We examined each model's ability to replicate key HFpEF characteristics, discuss their respective strengths and limitations, and highlight their role in supporting the creation of clinically relevant solutions. Additionally, the potential of emerging advancements is explored.
Source: Annals of Biomedical Engineering
Authors: Nina Langer, Andreas Escher, Caglar Ozturk, Andrew F. Stephens, Ellen T. Roche, Marcus Granegger, David M. Kaye, Shaun D. Gregory
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,390
Awards: G1428790767, A multidisciplinary approach to reducing complications with extracorporeal membrane oxygenation, Collaborative Research: Future Directions for Seafloor Geodesy Workshop 2020, LEVERAGING HIGH-FIDELITY SIMULATORS FOR PERSONALIZED THERAPEUTIC PLANNING IN FONTAN PATIENTS, Theorical and applied studies of error minimization in molecular evolution
OpenAlex ID: W4413600003
